Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marco Sposito
Observed name:
M. Sposito
Institutions:
University of Verona,
Azienda Ospedaliera Universitaria Integrata Verona
Observed institutions:
University of Verona,
Azienda Ospedaliera Universitaria Integrata Verona
ORCID:
0009-0004-6749-3214
Observed ORCID:
0009-0004-6749-3214
OpenAlex ID:
A5087385335
Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors
2023
·
Miriam Grazia Ferrara
, Lorenzo Belluomini
, et al.
·
Critical Reviews in Oncology/Hematology
·
54
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review
2024
·
Nicole Del Bianco
, Anita Borsati
, et al.
·
Critical Reviews in Oncology/Hematology
·
44
Infections and Immunotherapy in Lung Cancer: A Bad Relationship?
2020
·
Lorenzo Belluomini
, Alberto Caldart
, et al.
·
International Journal of Molecular Sciences
·
43
PDF
Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials
2023
·
Alice Avancini
, Anita Borsati
, et al.
·
Supportive Care in Cancer
·
40
PDF
Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome
2020
·
Ilaria Trestini
, Isabella Sperduti
, et al.
·
ESMO Open
·
36
Body composition derangements in lung cancer patients treated with first‐line pembrolizumab: A multicentre observational study
2024
·
Ilaria Trestini
, Lorenzo Belluomini
, et al.
·
Journal of Cachexia Sarcopenia and Muscle
·
32
PDF
Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates
2023
·
Lorenzo Belluomini
, Marco Sposito
, et al.
·
Cancers
·
32
PDF
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic
2020
·
Serena Zuliani
, Ilaria Zampiva
, et al.
·
European Journal of Cancer
·
32
PDF
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer
2023
·
Lorenzo Belluomini
, Alice Avancini
, et al.
·
Expert Opinion on Biological Therapy
·
26
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success
2024
·
Lorenzo Belluomini
, Alice Avancini
, et al.
·
Critical Reviews in Oncology/Hematology
·
25
Exercise and Bone Health in Cancer: Enemy or Ally?
2022
·
Alice Avancini
, Giulia Benato
, et al.
·
Cancers
·
23
PDF
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study
2022
·
Alice Avancini
, Ilaria Trestini
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
21
PDF
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done
2021
·
Lorenzo Belluomini
, Alessandra Dodi
, et al.
·
Translational Lung Cancer Research
·
21
PDF
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation
2024
·
Lorenzo Belluomini
, Ursula Cesta Incani
, et al.
·
Lung Cancer
·
18
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study
2024
·
Marco Sposito
, Lorenzo Belluomini
, et al.
·
Frontiers in Oncology
·
17
PDF
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode
2024
·
Alice Avancini
, Anita Borsati
, et al.
·
The Oncologist
·
17
PDF
Cardiac autonomic dysfunction in patients with cancer: exploring the role of physical exercise
2025
·
Anita Borsati
, Linda Toniolo
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
13
PDF
Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancer
2023
·
Alice Avancini
, Anita Borsati
, et al.
·
Asia-Pacific Journal of Oncology Nursing
·
13
PDF
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications
2024
·
Marco Sposito
, Serena Eccher
, et al.
·
Expert Review of Clinical Immunology
·
12
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients
2023
·
Annalisa Adamo
, Cristina Frusteri
, et al.
·
OncoImmunology
·
12
PDF
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis.
2022
·
Lorenzo Belluomini
, Sara Pilotto
, et al.
·
Seminars in Oncology
·
10
Meta-Analysis Exploring Tyrosine Kinase Inhibitor-Induced Weight Gain in Oncogene-Addicted NSCLC
2025
·
Ilaria Mariangela Scaglione
, Alice Avancini
, et al.
·
JTO Clinical and Research Reports
·
9
PDF
Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study
2024
·
Anita Borsati
, Diana Giannarelli
, et al.
·
Healthcare
·
7
PDF
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients
2023
·
Francesca Pettinella
, Chiara Lattanzi
, et al.
·
Cancers
·
7
PDF
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories
2023
·
Marco Sposito
, Lorenzo Belluomini
, et al.
·
Journal of Personalized Medicine
·
6
PDF
Show more works
View as search
Works count:
65
Citation count:
627
H-index:
16
I10-index:
21
Year
Topic
Type